Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

This study has been terminated.
(Replaced by another protocol)
Sponsor:
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota
ClinicalTrials.gov Identifier:
NCT00617929
First received: February 15, 2008
Last updated: April 10, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: January 2016
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)